Jennison Associates’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156M | Sell |
11,109,405
-251,470
| -2% | -$3.53M | 0.09% | 95 |
|
|
2025
Q1 | $178M | Sell |
11,360,875
-978,917
| -8% | -$15.3M | 0.12% | 86 |
|
|
2024
Q4 | $172M | Buy |
12,339,792
+676,295
| +6% | +$9.42M | 0.1% | 93 |
|
|
2024
Q3 | $108M | Buy |
11,663,497
+91,803
| +0.8% | +$854K | 0.07% | 130 |
|
|
2024
Q2 | $108M | Sell |
11,571,694
-604,621
| -5% | -$5.62M | 0.07% | 117 |
|
|
2024
Q1 | $121M | Buy |
12,176,315
+3,110,233
| +34% | +$30.8M | 0.08% | 102 |
|
|
2023
Q4 | $29.3M | Buy |
9,066,082
+4,633,907
| +105% | +$15M | 0.02% | 280 |
|
|
2023
Q3 | $23.5M | Buy |
4,432,175
+138,209
| +3% | +$734K | 0.02% | 291 |
|
|
2023
Q2 | $40.9M | Buy |
4,293,966
+2,079,476
| +94% | +$19.8M | 0.03% | 216 |
|
|
2023
Q1 | $24.4M | Buy |
2,214,490
+816,211
| +58% | +$8.98M | 0.02% | 300 |
|
|
2022
Q4 | $20.7M | Buy |
1,398,279
+8,663
| +0.6% | +$128K | 0.02% | 317 |
|
|
2022
Q3 | $26.6M | Buy |
1,389,616
+954,597
| +219% | +$18.2M | 0.03% | 276 |
|
|
2022
Q2 | $9.27M | Buy |
+435,019
| New | +$9.27M | 0.01% | 391 |
|